Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: J Neurointerv Surg. 2019 Aug 10;12(2):221–226. doi: 10.1136/neurintsurg-2019-014900

Table 2.

Exome-Variant Filtration Steps and Results of the Pedigree

Filtration Steps SNVs indels
Step 1): QC passed variants a 384102 45898
Step 2): novel variants b 204610 33009
Step 3): Protein-altering c or splice region variants 1589 478
Step 4): Variants segregated with disease d 14 3
Step 5): Variants predicted to be deleterious e 11 3
Candidate variants list 11 3
Step 6): familial segregation analysis f 4 2
Step 7): absent from the second-generation unaffected members 1 0
The final etiologic variant NFX1 c.2519T>C
a

SNVs and indel variants filtered by variant quality score recalibration (VQSR) measurement using GATK’s recommended parameters;

b

Novel variants, absent from public databases (ExAC_EAS);

c

Nonsynonymous, stop-gain, frameshift, start-lost, stop-lost;

d

Variants present in the three affected individuals (II-2, II-4, III-1) and absent in the phenotypically normal participants (II-5, III-4) sent for ES;

e

Variants predicted to be deleterious with CADD≥10 or truncating variants;

f

Variants segregated fully with definite IA phenotype in the family.